The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497

• Status: Completed
• Trial end date: 2019-03-21
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy and safety of CKD-497

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chong Kun Dang Pharmaceutical

Criteria

Inclusion Criteria:

1. 19 ≤ age < 75

2. Subject with acute upper respiratory infection and acute bronchitis infection

3. Subject who agreeds to participate in this clinical trial voluntarily

Exclusion Criteria:

1. Subject who need antibiotics treatment during the clinical trial

2. Subject suffering from severe respiratory diseases such as pneumonia, asthma, chronic closed lung diseases (COPD), tuberculosis, bronchial enlargement, malignant tumors in the lungs, and chronic bronchitis during screening

3. Subject who cannot participate in a clinical trial based on the PI's judgment